These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38318988)

  • 1. Hyaluronan-Sphingosine Polymersomes for Treatment of Ocular Neovascularization: Synthesis and Evaluation.
    Yetisgin AA; Durak S; Kutlu O; Cetinel S
    Macromol Biosci; 2024 Jun; 24(6):e2300531. PubMed ID: 38318988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembled oleylamine grafted hyaluronic acid polymersomes for delivery of vancomycin against methicillin resistant Staphylococcus aureus (MRSA).
    Walvekar P; Gannimani R; Salih M; Makhathini S; Mocktar C; Govender T
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110388. PubMed ID: 31369955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenesis effects of endostatin in retinal neovascularization.
    Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
    Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX
    J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid coating of gold nanoparticles for intraocular drug delivery: Evaluation of the surface properties and effect on their distribution.
    Apaolaza PS; Busch M; Asin-Prieto E; Peynshaert K; Rathod R; Remaut K; Dünker N; Göpferich A
    Exp Eye Res; 2020 Sep; 198():108151. PubMed ID: 32721426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiogenesis by HC·HA, a complex of hyaluronan and the heavy chain of inter-α-inhibitor, purified from human amniotic membrane.
    Shay E; He H; Sakurai S; Tseng SC
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2669-78. PubMed ID: 21228375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid modified MPEG-b-PAE block copolymer aqueous micelles for efficient ophthalmic drug delivery of hydrophobic genistein.
    Li C; Chen R; Xu M; Qiao J; Yan L; Guo XD
    Drug Deliv; 2018 Nov; 25(1):1258-1265. PubMed ID: 29847210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization.
    Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
    Curr Eye Res; 2021 Oct; 46(10):1551-1558. PubMed ID: 33870816
    [No Abstract]   [Full Text] [Related]  

  • 9. A sustained release formulation of novel quininib-hyaluronan microneedles inhibits angiogenesis and retinal vascular permeability in vivo.
    Galvin O; Srivastava A; Carroll O; Kulkarni R; Dykes S; Vickers S; Dickinson K; Reynolds AL; Kilty C; Redmond G; Jones R; Cheetham S; Pandit A; Kennedy BN
    J Control Release; 2016 Jul; 233():198-207. PubMed ID: 27086168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxalomalate reduces expression and secretion of vascular endothelial growth factor in the retinal pigment epithelium and inhibits angiogenesis: Implications for age-related macular degeneration.
    Kim SH; Kim H; Ku HJ; Park JH; Cha H; Lee S; Lee JH; Park JW
    Redox Biol; 2016 Dec; 10():211-220. PubMed ID: 27810736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-181a inhibits ocular neovascularization by interfering with vascular endothelial growth factor expression.
    Yang C; Tahiri H; Cai C; Gu M; Gagnon C; Hardy P
    Cardiovasc Ther; 2018 Jun; 36(3):e12329. PubMed ID: 29608244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting retinal and choroid neovascularization using the small molecule inhibitor carboxyamidotriazole.
    Afzal A; Caballero S; Palii SS; Jurczyk S; Pardue M; Geroski D; Edelhauser H; Hochhaus G; Kim M; Franklin A; Shapiro G; Grant MB
    Brain Res Bull; 2010 Feb; 81(2-3):320-6. PubMed ID: 19679174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.
    Chang CY; Wang MC; Miyagawa T; Chen ZY; Lin FH; Chen KH; Liu GS; Tseng CL
    Int J Nanomedicine; 2017; 12():279-294. PubMed ID: 28115846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways.
    Son Y; Lim D; Park S; Song IS; Kim JH; Shin S; Jang H; Liu KH; O Y; Song GY; Kang W; Cho YS; Na M; Chung H; Oh S
    Pharmacol Res; 2020 Nov; 161():105146. PubMed ID: 32814173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PlGF silencing combined with PEDF overexpression: Modeling RPE secretion as potential therapy for retinal neovascularization.
    Araújo RS; Silva GA
    Mol Biol Rep; 2020 Jun; 47(6):4413-4425. PubMed ID: 32385771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel sphingosine-1-phosphate receptor 1 antagonist prevents the proliferation and relaxation of vascular endothelial cells by sphingosine-1-phosphate.
    Yonesu K; Nakamura T; Mizuno Y; Suzuki C; Nagayama T; Satoh S; Nara F
    Biol Pharm Bull; 2010; 33(9):1500-5. PubMed ID: 20823564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Factor H Expressed by Retinal Pigment Epithelium Cells Can Suppress Neovascularization of Human Umbilical Vein Endothelial Cells: An in vitro Study.
    Zhang Y; Huang Q; Tang M; Zhang J; Fan W
    PLoS One; 2015; 10(6):e0129945. PubMed ID: 26091360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of pathological retinal neovascularization by semaphorin 3A.
    Yu W; Bai Y; Han N; Wang F; Zhao M; Huang L; Li X
    Mol Vis; 2013; 19():1397-405. PubMed ID: 23825919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockout of αA-crystallin inhibits ocular neovascularization.
    Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siponimod As a Novel Inhibitor of Retinal Angiogenesis: In Vitro and In Vivo Evidence of Therapeutic Efficacy.
    Alshaikh RA; Zaki RGE; El Din RAS; Ryan KB; Waeber C
    J Pharmacol Exp Ther; 2023 Aug; 386(2):224-241. PubMed ID: 37188532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.